Tuesday, January 11, 2022

< + > Medicare Seeks To Limit Coverage For Controversial Alzheimer’s Drug Aduhelm

Doctors demanded the FDA revoke its approval for the Alzheimer’s drug Aduhelm, which can cause side effects like brain bleeding.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Weekly Roundup – August 8, 2026

Welcome to our Healthcare IT Today Weekly Roundup . Each week, we’ll be providing a look back at the articles we posted and why they’re impo...